Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

Saved in:
Bibliographic Details
Published in:Gynecologic oncology Vol. 154; pp. 50 - 51
Main Authors: Liu, Y.L., Emengo, V.N., Friedman, C.F., Konner, J., O'Cearbhaill, R.E., Aghajanian, C.A., Zamarin, D.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-06-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author O'Cearbhaill, R.E.
Liu, Y.L.
Aghajanian, C.A.
Emengo, V.N.
Friedman, C.F.
Konner, J.
Zamarin, D.
Author_xml – sequence: 1
  givenname: Y.L.
  surname: Liu
  fullname: Liu, Y.L.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 2
  givenname: V.N.
  surname: Emengo
  fullname: Emengo, V.N.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 3
  givenname: C.F.
  surname: Friedman
  fullname: Friedman, C.F.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 4
  givenname: J.
  surname: Konner
  fullname: Konner, J.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 5
  givenname: R.E.
  surname: O'Cearbhaill
  fullname: O'Cearbhaill, R.E.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 6
  givenname: C.A.
  surname: Aghajanian
  fullname: Aghajanian, C.A.
  organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA
– sequence: 7
  givenname: D.
  surname: Zamarin
  fullname: Zamarin, D.
  organization: Weill Cornell Medical College, New York, NY, USA
BookMark eNp9kMtOwzAQRS1UJNrCF7DxDySMnYftBQtU8ZIqIUT3lmtPwFXrFDuJlL8npaxZzWLmXN05CzILbUBCbhnkDFh9t8vHzzG0OQemcihzxvkFmTNQVVbLSs3IHEBBJnklr8gipR0AFMD4nLx_9NuE3z2GjnZfGM3RY6ImOJr6OPjB7KlpOozUHw59aM8nI_WBRrR9jCeuHUz0JlBrgsV4TS4bs0948zeXZPP0uFm9ZOu359fVwzqzSvLM1XW5ZUKYrRQNs7JkTjnJCqwFcsGtsrYsTN0wVCiUZdOmsk4aWYFwCGWxJMU51sY2pYiNPkZ_MHHUDPRJit7pXyn6JEVDqScpE3V_pnBqNniMOlmPU23np3867Vr_L_8DjJFv9w
ContentType Journal Article
Copyright 2019
Copyright_xml – notice: 2019
DBID AAYXX
CITATION
DOI 10.1016/j.ygyno.2019.04.122
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1095-6859
EndPage 51
ExternalDocumentID 10_1016_j_ygyno_2019_04_122
S0090825819306201
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29I
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LCYCR
LG5
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OQ.
OZT
P-8
P-9
P2P
PC.
PH~
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
UHS
UV1
WUQ
X7M
XPP
Z5R
ZGI
ZMT
ZU3
ZXP
~G-
AAXKI
AAYXX
AFJKZ
AKRWK
CITATION
ID FETCH-LOGICAL-c982-d664b177ab87f1c841d9d813e67e272c9cc43a6f1e9e79c113e5cd8a8507de043
ISSN 0090-8258
IngestDate Thu Sep 26 17:59:50 EDT 2024
Fri Feb 23 02:21:49 EST 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c982-d664b177ab87f1c841d9d813e67e272c9cc43a6f1e9e79c113e5cd8a8507de043
PageCount 2
ParticipantIDs crossref_primary_10_1016_j_ygyno_2019_04_122
elsevier_sciencedirect_doi_10_1016_j_ygyno_2019_04_122
PublicationCentury 2000
PublicationDate June 2019
2019-06-00
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: June 2019
PublicationDecade 2010
PublicationTitle Gynecologic oncology
PublicationYear 2019
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0003012
Score 2.3242347
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 50
Title Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
URI https://dx.doi.org/10.1016/j.ygyno.2019.04.122
Volume 154
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9swEBZbB2Uvpds61rUdetjbahPZ8tl6LG3SsHWFtWGMvRhHkksKc0raFPzf9_TDP9KMsg32YoyCE6H7cro73_eJkI9RASABdACCJ5iglINgqpgMQKVRgXdM22M6x5fp-Y_sZMiHXU23G_uvlsYxtLVhzv6FtdsvxQG8R5vjFa2O1z-yu_EEtj3akhQXxQ2mwvYNwe0SvcK9kQawx4LPDDHE069qx2qRXqtpfo8JNP7vpUHEoh--ntaVls5dfppXcqUkfzZbWn8enoVtmP5LV1e2Fvs9PG9HR5idK194PQ5H7fiXeXMM2OewX4ww_CfoFyNalsxKEyeGcYau7iTaQ-0cLYZ2AWReDbzxxAnv-VInSOt3ZadKu-bvXenhOqyv6spQOZkwwrXMUZ0fCWlfmnmYaWDMOoDIkP5eROieTCPoz-Si3b_R5TmNeT_rRqvKdgWu_dDv45lejDLZJls-uaBHDhWvyDNdvSabX337xBvyrQMHbcFBERy0AQe14KAr4KCzirbgoB4c1IFjh0xGw8nxOPBnagRSYC6lALgRHCumWVoymXGmhMpYrCHVURpJISWPCyiZFjoVkuEnRj2iyDBtUHrA47dko5pX-h2hqhTplHEJGhIusmKKuyYvQUGsFJQx2yWHzcLkN045JW9aCq9zu465Wcd8wHNcx10CzeLlPvhzQV2Otn7qwff_-uAeedlBeJ9s3C2W-oA8v1XLDxYQD0O1fWk
link.rule.ids 315,782,786,27935,27936
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subsequent+therapies+and+survival+after+immunotherapy+in+recurrent+ovarian+cancer&rft.jtitle=Gynecologic+oncology&rft.au=Liu%2C+Y.L.&rft.au=Emengo%2C+V.N.&rft.au=Friedman%2C+C.F.&rft.au=Konner%2C+J.&rft.date=2019-06-01&rft.pub=Elsevier+Inc&rft.issn=0090-8258&rft.eissn=1095-6859&rft.volume=154&rft.spage=50&rft.epage=51&rft_id=info:doi/10.1016%2Fj.ygyno.2019.04.122&rft.externalDocID=S0090825819306201
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon